SCHEMBL7378144

SCHEMBL7378144

O=C1OC[C@H]2CCc3cc(O)ccc3N12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.49
ESR1 P03372 7/20 0.37
ESR2 Q92731 7/20 0.37
SRD5A1 P18405 2/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
OPRK1 P41145 1/20 0.36
CYP26A1 O43174 1/20 0.35
HSD17B1 P14061 2/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
HSP90AA1 P07900 2/20 0.34
PDK1 Q15118 2/20 0.34
PDK2 Q15119 2/20 0.34
PDK3 Q15120 2/20 0.34
PDK4 Q16654 2/20 0.34
AKR1B10 O60218 1/20 0.34
LMNA P02545 1/20 0.34
SHBG P04278 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7340995 1.00 NOTUM (0.49) NOTUMESR1ESR2SRD5A1DRD2
SCHEMBL7372067 1.00 NOTUM (0.49) NOTUMESR1ESR2SRD5A1DRD2
SCHEMBL16587000 0.83 NOTUM (0.49) NOTUMSRD5A1OPRK1OPRM1
SCHEMBL16589999 0.83 SRD5A1 (0.51) NOTUMSRD5A1
SCHEMBL7366736 0.80 HTR2C (0.49) NOTUMSRD5A1DRD2DRD3HTR2B
SCHEMBL8742792 0.80 HTR2C (0.49) NOTUMSRD5A1DRD2DRD3HTR2B
SCHEMBL7342239 0.80 HTR2C (0.49) NOTUMSRD5A1DRD2DRD3HTR2B
SCHEMBL7310227 0.79 NOTUM (0.71) NOTUMSRD5A1DRD3OPRK1SLC6A4
SCHEMBL16586191 0.76 NOTUM (0.42) NOTUMSRD5A1
SCHEMBL3381538 0.74 OXTR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699680-B1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SANOFI SYNTHELABO (FR) 2000-03-08 EP disclosed
US-5641785-A ANTIDEPRESSANTS, NERVOUS SYSTEM DISORDERS SYNTHELABO (FR) 1997-06-24 US disclosed
EP-0699680-A1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1996-03-06 EP disclosed